Veeda Clinical IPO

Veeda Clinical IPO Details

Check out the issue details for Veeda Clinical IPO as disclosed in SEBI.

Price Band

Not Issued

Issue Size

831.6 Cr.

Issue Type

Book Built

Open

Not Issued

Close

Not Issued

Veeda Clinical News

 IPO news not found.

Company Financials

You can get the following financial statements of Veeda Clinical as of now.

Company Name

Veeda Clinical

  Profit Loss
  Balance Sheet
  Quarterly
  Shareholding
  Cash Flow

The approx valuation of Veeda Clinical Research IPO based on its price band and DRHP/RHP is:

Particulars Value
Upper Price Band Not issued
Existing Shares (Qty) 4.62 Cr
Fresh Issue 331.6 Cr
EPS (FY21) Rs 15.39

 

Veeda Clinical Research IPO issue size is 831.6 Cr:

Issue Amount
Fresh Issue 331.6 Cr
Offer For Sale 500 Cr

 

The category-wise shares offered are as follows:

Category % Offered
Qualified Institutional Maximum 50%
Non-Institutional Minimum 15%
Retail Individual Minimum 35%
Employee  Not Disclosed

The dates for the IPO is not issued yet. Check this space later on.

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 195.81 223.93 296.15 275.45 262.43
Total Expenditure 129.1 182.85 241.74 247.49 256.95
Operating Profit 66.72 41.08 54.42 27.96 5.48
Other Income 38.57 4.23 9.15 17.56 21.84
Interest 4.81 4.58 5.33 5.87 5.34
Depreciation 14.95 15.53 21.13 35.02 37.01
Exceptional Items 0 0 0 0 0
Profit Before Tax 85.53 25.2 37.1 4.63 -15.04
Provision for Tax 22.25 6.87 11.15 1.57 -3.62
Net Profit 63.29 18.33 25.95 3.06 -11.42
Adjusted EPS (Rs.) 1.76 0.35 0.49 0.05 -0.17

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 35.83 10.58 10.58 12.6 13.16
Total Reserves 133.93 463.18 510.6 879.44 999.18
Borrowings 0 0 0 0 0
Other N/C liabilities 34.8 27.48 34.54 48.35 55.18
Current liabilities 74.75 88.68 96.4 89.16 86.92
Total Liabilities 279.31 589.91 652.11 1029.55 1154.43
Assets
Net Block 74.36 69.7 105.72 162.49 149.6
Capital WIP 0.46 8.84 4.69 6.32 8.92
Intangible WIP 0.67 1.37 3.32 0.11 0.18
Investments 37.02 165.13 213.15 510 725.93
Loans & Advances 41.38 26.02 25.91 30.9 31.41
Other N/C Assets 4.89 13.7 36.51 11.08 2.38
Current Assets 120.52 305.16 262.82 308.65 236.02
Total Assets 279.31 589.91 652.11 1029.55 1154.43
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2024 Mar 2025
Profit from operations 4.63 -15.04
Adjustment 28.75 48.08
Changes in Assets & Liabilities -9.59 -19
Tax Paid -3.26 0.08
Operating Cash Flow 20.52 14.11
Investing Cash Flow -229.12 3.94
Financing Cash Flow 195.88 -17.55
Net Cash Flow -12.73 0.5
X